Company

Vistin Pharma ASA

Headquarters: Oslo, Norway

Employees: 67

CEO: Mr. Magnus Tolleshaug

OSE: VISTN

Market Cap

kr975.6 Million

NOK as of July 1, 2024

US$91.5 Million

Market Cap History

Vistin Pharma ASA Categories

Healthcare Drug Manufacturers—Specialty & Generic

Vistin Pharma ASA market capitalization over time

Evolution of Vistin Pharma ASA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Vistin Pharma ASA

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $70.87 B
MERCK Kommanditgesellschaft auf Aktien $55.96 B
Takeda Pharmaceutical Company Limited $48.34 B
Haleon plc $46.46 B
Hansoh Pharmaceutical Group Company Ltd $23.59 B
Sector:
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Detailed Description

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.

Stocks & Indices

Vistin Pharma ASA has the following listings and related stock indices.


Stock: OSE: VISTN wb_incandescent

Details

Headquarters:

OestensjOeveien 27

Oslo, 0661

Norway

Phone: 47 35 98 42 00